Performance Measurement Network

List of All Questions in the FAQ Database

Clinical Specification Questions

Question Related to
Statin prescibed the day after discharge STK-06, STK-08
How should we abstract pharmacological VTE prophylaxis when the patient is NPO? STK
Appointment for Follow Up/ Release of Information HBIPS, HBIPS-7
Reason for No VTE Prophylaxis STK, STK-01
ABstraction for Date Last Known Well STK
Can estimated blood loss (EBL be used for the data element pre-transfusion hemoglobin/hematocrit.) BM-02
HBIPS-1 Timeframe for Screening Questions HBIPS
Failed Attempt at Thrombectomy CSTK-08, CSTK-11, CSTK-12
Small vessel disease as Evidence of Atherosclerosis STK, STK-06
Pneumonia diagnosis: ED/Direct Admint PN
AMA and Number of Antipsychotic Meds Prescribed at Discharge HBIPS-4, HBIPS-5
Is Xarelto an antithromotic for use in Stroke? Can it be used for antithrombotic med at discharge? STK, STK-02
Mother's choice not to breast feed PC-05
First Pass of a Mechanical Reperfusion Device / First Pass Time CSTK, CSTK-05
MER Eligibility CSTK
Non Aneurysmal SAH Documentation CSTK-06
Earliest Reperfusion Procedure Date/Time for transferred patients CSTK-01
Earliest Aneurysm Repair or Surgical Interv Procedure Time CSTK
OBS: remains in the ED or transfer to another unit not in the ED STK-OP
Patients with subsequent admissions to the psychiatric unit HBIPS-1, HBIPS-6, HBIPS-7
Data Element Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Prescribed for LVSD at Discharge has an incomplete sentence ACHF-01
Patients transferred after t-PA STK
Arrival Time for STK, CSTK and STK-OP Measures STK
Psychiatic Care Setting -Patient Inclusion HBIPS
HBIPS Event Dates Prior to Admission HBIPS
Late Coded Stroke STK-4 and STK-5 STK, STK-4
Rationale for Code Stroke Form as the Priority Data Source STK-4
CSTK4 documentation time? CSTK-04
Can a patient undergoing Cardiac Surgery who received RBC's, FFP and Platelets be counted for more than one measure? BM
Can an addendum be added to the medical record? STK-01
Will certified Primary Stroke Centers be required to report the stroke performance measures as core measures? STK
What dosage of Lovenox is suffiecient to meet antithrombotic therapy administered by end of hospital day 2 STK-05
SCIP- Neuraxial Anesthesia- Epidural for pain control placed post-op SCIP
Reason for No Anticoagulation Therapy Prescribed at Discharge STK-03
What should we do when conflicting or multiple times of last known well are documented? STK-04
Stroke VTE Prophylaxis STK-01
Is intensive dosing of statin required to meet STK-6? STK
Reason for no VTE Prophylaxis - Elevated INR STK, STK-01
Stroke Education Documentation Examples STK-08
First NIHSS performed days after admission CSTK-01
CSTK-01 Procedures and Timing 1 calculation CSTK-01
STK-6 Data Entry in CMIP for Q1 2010 STK
Proof that next level of care provider contact information was transmitted with the Transition of Care Record ACHF
Data abstraction for VTE Prophylaxis when administered prior to admission STK
Pre-transfusion platelet count allowable value BM-04b
what if Pradaxa (dabigatran is prescribed at discharge?) STK-02
What terms can be used for Comfort Measures Only? STK
Transmission of Continuing Care Plan (CCP) HBIPS, HBIPS-7
Time Last Known Well is after hospital arrival STK-04
Will Primary Stroke Certification continue? STK
Stroke after admission-arrival to skin puncture CSTK -09 CSTK
Written discharge instructions for warfarin therapy VTE-05
Referral to Next Level of Care HBIPS
What is the Date and Time Last Known Well? STK-04
Time NIHSS performed CSTK-01
Assessed for Rehabilitation STK
Referral to Next Level of Care Provider-Trasmittal Question HBIPS-6
Consideration of PRADAXA as anticoagulation therapy for patients with atrial fibrillation STK-03
STK-4 IV Thrombolytic Therapy STK
Support System ACHF
Admitted for elective carotid intervention STK
IV Alteplase STK-OP
Why has this indicator has changed to include the word "elective"? STK
Number of cases needed for submission BM
Why are there not more contraindications to vaginal deliveries? PC
How is Length of Stay (LOS calculated for STK-1?) STK-01
Stroke Module STK
in 2016, will the vendors still be able to submit STK HCD for STK Certification for our hospitals? STK
Will files be rejected if all procedure codes do not have a procedure time? CSTK, CSTK-01, CSTK-03
Reason for Not Prescribing Anticoagulation Therapy at Discharge STK-03
Risk of Violence to Self HBIPS, HBIPS-1
Significance of baseline mRS in calculation of CSTK-10 CSTK-10
Last Known Well STK-04
Continuing Care Plan Document Questions HBIPS
Why is a Reason for No VTE Prophylaxis needed with graduated compression stockings (GCS/TEDs?) STK, STK-01
Why does a patient on another lipid-lowering medication qualify and fail statin prescribed at discharge? STK-06
Activity specifics ACHF
Last known well when symptoms resolve then reoccur STK
Documentation for Rehabilitation Assessment STK-10
Should 'Yes' or 'No' be selected for IV Thrombolytic Initiation? STK
Time Last Know Well -Stroke STK
Can documentation on a pre-printed stroke order form for VTE Prophylaixs be used as a sufficient reason for no prophylaxis? STK-01
TEDS for VTE Prophylaxis STK, STK-01
Why does a patient treated with another lipid-lowering agent and with LDL < 100 fail the statin measure? STK-06
Earliest principal procedure time/first pass time CSTK
Clarification of data elements needed CSTK-05b, CSTK-07
NIHSS Timed After Discharge CSTK-01
CSTK 4 Denominator Population CSTK-04
Why is ICD-9-CM Principal Diagnosis Code 436 used for ischemic stroke? STK
Is refusal of all IV's a Reason for Not Initiating IV Throbolytic Therapy? STK-04
Discharge Medications and Indication for Use HBIPS-6, HBIPS-7
What are the benchmarks for the new Outpatient Stroke Core Measures? STK-OP
Clarification of CSTK-1 Measure Population Requirements CSTK-01
Documentation for tPA exclusion STK, STK-04
If the patient enters the ED as a potential or actual TIA or hemorrhagic stroke patient, are the ED physicians required to document why the patient did not have IV thrombolytics initiated? STK
Definition of validated and non-validated screening tool for substance use SUB-01
Are MRI reports an acceptable data source for Evidence of Atherosclerosis? STK-06
Reason for Extending the Initiation of IV Thrombolytic STK, STK-04
What would I document as Last Known Well? STK, STK-4
Denominator exclusion population ICD-9 CM diagnosis codes CSTK, CSTK-03
Continuing Care Plan - Reason for Hospitalization HBIPS
First Radiographic Image, CSTK 07 STK
Documentation added to D/C summary after discharge STK-6
Next Level of Care Provider Same as Hospital Provider HBIPS
Evidence of Atherosclerosis STK
Exclusive breast milk feeding definition PC
Will Evidence of Atherosclerosis remain a data element? STK-06
Can I use VTE used during the Observation, given prior to hospital admission STK-1
Are patients who have ischemic stroke occured after hospital arrival included in CSTK-01 population CSTK-01
Sampling when both STK and CSTK are collected by a HCO CSTK
Refusal of SCD's STK, STK-01
Procedures Performed During Hospitalization ACHF
Are retired Stroke Core Measures still required for comprehensive stroke centers? STK
Does the following documentation meet education regarding Risk factors for stroke? STK
NIHSS Score Clarification CSTK-01
Patient Receiving Continuing Care Plan Only HBIPS-6, HBIPS-7
Is admission day counted as day 1 for STK-1? STK
Elective carotid intervention documentation STK
STK-6 Reason for Not Prescribing a Statin Medication at Discharge STK
Why aren't there more newborn conditions listed for not exclusively feeding breast milk? PC-05
Can post discharge documentation of a statin prescription be used in abstraction? STK-06
What version of the Joint Commision manuel will be used starting with January 1, 2010? STK-01, STK-02, STK-03, STK-04, STK-05, STK-06, STK-07, STK-08, STK-09, STK-10, VTE
Stroke Diagnosed Mid-Hospital Stay STK-5
Follow-up to UserQuestion102705 CSTK
Version 4.4 - Time Last Known Well and Reason Extending IV Thrombolytic STK-04
Stroke that occurs after admission CSTK
Sampling Requirements for CSTK CSTK
Transfer in patients that are intubated CSTK-01
Importance of exclusive breast milk feeding PC
Time of the teleneurology NIHSS CSTK-01
Graduated Compression Stocking (GCS) STK
Abstraction for Clinical Trial (STK ) STK
Antithrombotic Administration after t-PA STK-05
Is Xarelto (Rivaroxaban an acceptable anticoagulant for STK-3?) STK-03
Hunt & Hess/ ICH score documentation required by tele neuro radiology prior to transfer STK
Time Last Known Well - Conflicting Physician Documentation STK-04
What is the Admission Date? STK
Thrombolytic therapy administered at satellite ED prior to hospital arrival STK
Documention of Stroke education at discharge, STK-08
Does all medical record documentation need to be dated and timed? STK
Question regarding the new STK OP 1 Measure STK-OP
Admission Date STK-01
Is heparin 5000U SQ acceptable for antithrombitic administered by end day 2 STK
Comprehensive Stroke (CSTK Sub-Populations) CSTK
Please submit all CMS mortality measure questions directly to QnetQuest.org MORT
What is the Date and Time of Last Well Known? STK-04
SCIP Inf-9 Urinary catheter removed on Postoperative Day 1 (POD 1 or Postoperative Day 2 (POD 2) with day of surgery being day zero ) SCIP, SCIP Inf-9
Sampling Requirements for CSTK CSTK
Statins at Discharge STK-06
Documentation for Stroke Education HF-1
Elective Carotid Intervention STK
Data Element- Violence Risk to Self HBIPS
If tPA is given at an outside hospital by our Critical Transport Team, should we take credit? STK, STK-04
Procedure Time Inclusion Terms CSTK-03
Abstraction for Last Known Well STK-04
Stroke Measure Requirements STK
PSC CSTK 01 population CSTK, CSTK-01
Transfer between the Psychiatric Unit and Acute Care Unit HBIPS
Is full medication reconciliation required by PSCs to meet the Medication Education measure component? STK-08
How should we abstract thrombolytic administration in the 3 to 4.5 hr timeframe when a reason for not administering existed within 3 hrs? STK, STK-04
Are patients that stroke while an inpatient included in the measure population? STK
Hunt and Hess & ICH Score Documentation CSTK-03
MER code for combined billing for two hospitals-TSC CSTK, CSTK-08
Reason for not giving Nimodipine within 24 hours CSTK
Primary Stroke Certification and Transition to Stroke Core Measures STK
Birth Weight suggested Sources PC-06
Statin therapy for patients 75yrs and older STK
Retirement of STK-7 Dysphagia Screen STK-07
Lovenox 40mg daily - Antithrombotic Therapy Administered by End of Hospital Day Two STK
Please submit all outpatient questions to QnetQuest.org OP
MER Attempted During this Encounter - Clot Dissolved CSTK-11
Arrival time for transferred patients CSTK-07
Please submit all Emergency Department measure questions directly to QnetQuest.org ED, ED-1, ED-2
STK-5 Antithrombotic - LOVENOX SQ STK
Reason for Not Initiating IV Thrombolytic-conflicting GWTG instructions STK-04
Positive Brain Image CSTK
Jan 2012 Follow-up monitoring VTE-05
If a physician writes an order for SCDs, is this sufficient to select 'Yes' for VTE Prophylaxis? STK-01, VTE-01
Time Last Known Well STK
Documentation of Last Known well STK, STK-4
NIHSS versus mNIHSS CSTK-05
Documentation of Stroke Education STK-08
Will Evidence of Atherosclerosis remain a STK-6 data element? STK
One Episode of Care and Thrombolytic Therapy Administration STK
Reason for No VTE Prophylaxis - Hemorrhagic Stroke Patient STK-01
Patient Referral to Next Level of Care Provider HBIPS
Can the following note be used as a Reason for Not Prescribing Anticoagulation Therapy? STK-03
can we accept a Drs documentation that it is not a hemorragic transformation CSTK, CSTK-05
doucumentation of ich and hunt hess CSTK-03
VTE Prophlyaxis - Abstracting of Allowable Values STK-01
What are the recommendations for VTE prophylaxis for stroke patients? STK-01
Who should perform mRS? CSTK-02
Does a hold on anticoagulation count as a valid reason for not prescribing at discharge? STK-03
Assessed for Rehabaliitation Services STK-10
Questions about sampling? ACHF
STK-10 Assessed for Rehabilitation Services STK-10
Stroke Measures STK-7 and STK-9 STK
Recommended ways to obtain mRS CSTK, CSTK-02
Covid Vaccine Audit HCSS
Triglyceride >400mg/dL STK
In the Operating Room, is "Estimated Blood Loss" for PRBC'S considered transfusion criteria? BM-02
Unable to Calculate LDL Value Due to High Triglycerides STK-06
What is the purpose of the Missing Branch ('X' Category Assignment for VTE Prophylaxis Date?) STK-01
Follow-up to UserQuestionId03Vte101043 VTE-05
Follow-up to UserQuestionId03Stk100628 STK
Last Known Well STK, STK-04
Multiple TICI reperfusion grades CSTK-08
Reason For Not Administering Antithrombotic By End of Hospital Day 2 STK
Do we need to collect 90 day mRS on pts undergoing CEA/CAS? CSTK
Multiple Procedure Times CSTK, CSTK-01
Multiple EMRs HBIPS
Functional Status at Discharge ACHF
What number should we enter for the denominator? HCSS-6
How do I determine my firm group? HCSS
Will the new AHA recommendation of expasion of the time window for treatment wiht tPA be included in TJC measures/STK4? Other
thyroid CA PC-01
For Q1 2013 fVTE and Oral Factor Xa inhibitor in Stroke patients. STK-01
Lovenox in reference to STK-2, STK-5, and STK-3 STK-2, STK-3, STK-5
Does CSTK - 03 include directly admitted transfers (that bypass ED?) CSTK-03
Why aren't more exclusions to elective delivery considered? PC
HBIPS Discharge Status HBIPS
Does Appendix H, Table 2.2 exclude ambulatory stroke patients from the VTE prophylaxis? STK
When there is a discharge summary and an addendum present in the medical record, which should be used? STK
Initial Date/time of NIHSS teleneurologist CSTK, CSTK-01
Must the patient refuse both pharmacological and mechanical VTE prophylaxis to count as a reason for no prophylaxis? STK-01
Code 433.10 and Transient Ischemic Attack STK
Dietary Advice "consistent amount" of foods with Vitamin K rather than avoidance should be advised. VTE-05
Pre-anemia screening BM
Continuing Care Plan-Discharge Medications Indications for Use HBIPS
Reason for not prescribing antithrombotic therapy at hospital discharge STK
Does the reason for not presciribing anticoagulation therapy have to be documented on the dau of discharge? STK-03
Are the following examples acceptable Reasons for Not Prescribing Anticoagulation and Antithrombotic Therapy at Discahrge? STK, STK-02
CSTK Procedure Times CSTK
PRE-stroke Modified Rankin Indicator question for Cstroke reporting CSTK-02
Which version of the specifications should be used for stroke data collection? STK
COVID-19 CSTK
Procedure codes for HF outpatients ACHF
Data Abstraction for "Last Known Well" STK
What constitutes a failed thrombectomy CSTK-11
Arrival time Abstraction. CSTK-11
Documentation Compliance for IV t-PA STK, STK-04
Follow-up to UserQuestionId03Stk100984 STK-04
Dabigatran (PRADAXA use in Stroke Patients) STK
When mutiple ejection fractions (EF are documented in the medical record, which value should we use?) ACHF
Rehabilitation Assessment STK
STK-1: IV Heparin for VTE Prophylaxis STK, STK-01
CSTK 02, 05, and 06 Measures CSTK-01, CSTK-02, CSTK-05, CSTK-06
Discharge Instructions for Activation of Emergency Medical System (EMS (911)) STK-08
Do I need to enter this data again or can I just start with January? HCSS
mRS CSTK
Clairfy time to recanalization CSTK, CSTK-07
Can we use E/M code 99211? ACHF
Sampling Methodology for Stroke STK
How to Answer Questions on Advanced Stroke Tab Intent to Perform MER CSTK-08
SUB 2 SUB
STK-6 "Evidence of Atherosclerosis" STK
DVT Prophylaxis and Ambulation STK, STK-01
Use of Sweet-Ease速 and PC-05 (Exclusive Breast Milk Feeding) PC-05
Stroke core measure data for PSC hospitals STK
ICD-9-CM Code 433.10 STK
Date Last Known Well STK
Appropriate Justification for Multiple Antipsychotic Meds at DC - Rationale for Allowable Value 4 HBIPS
Are patients admitted for elective basilar stenting excluded from the stroke chart audits? STK
LDL Measured within first 48 hrs or 30 days prior to hospital arrival STK
Date/Time of First Pass for CSTK-7 CSTK
When both SCDs and TEDS are applied on the same day , how are they abstracted? STK
Graduated Compression Stockings as VTE Prophylaxis for Stroke Patients (STK-1) VTE-01, STK-1
Is it considered CMO if the palliative care consult was done and the patient refuses palliative care the next day? STK
Initial Blood Pressure at Hospital Arrival Field Format CSTK-03
Pradaxa (dabigatran prescribed at discharge) STK-02
History of low vertical incision documented BUT no documentation of classical incision. PC-01
SCIP questions related to the April 2010 manual SCIP
HBIPS- Restraint and Seclusion in ED HBIPS-3
Abstraction Tools ASR-OP-1
Last Known Well Version 5.2 STK-4
Documentation ofJustification for Multiple Antipsychotic Medications HBIPS
Inter-rater Reliability and Chart Re-asbstraction STK
Numerator Statement HCSS
Reason for Not Administering Antithrombotic Therapy? STK
Expired after discharge CSTK-02
Need information about the required import file specifications BM
Footling breech code 652.81 as an exclusion for PC-02 PC-02a
WIll the new medication Pradaxa be acceptable as an anticoagulant at discharge? STK, STK-03
If the admitting diagnosis is not stroke, can the case be excluded from STK-4? STK-04
Reason for Not Initiating IV Thrombolytic STK
CSTK 3 CSTK, CSTK-03
Define who is considered a stroke team for STK 4. STK
Comparative Data for Stroke Measures STK
Is there benchmark data available for HBIPS Data? HBIPS, HBIPS-1, HBIPS-1b, HBIPS-1c, HBIPS-1d, HBIPS-1e
PSC Certified Hospitals: Sampling Methodology to Use for CSTK 1 for 2019 STK
Why are patients that receive t-PA in the ED and then transferred to another hospital excluded from STK-4? STK-04
Patient Population CSTK
activity charting ACHF
STK 10 Assessed for rehabilitation STK-10
How to abstact Last Known Well when there is too much information? STK
Reason for Not Prescribing Antithrombotic / Anticoagulation at Discharge STK-02
ICH score documentation CSTK-03b
Failed attempt at thrombectomy CSTK-08
Optimal Medication Management ACHF
Last Known Well Y/N? STK-4
What dose of enoxaparin is acceptable for use as antithrombotic therapy. STK-2, STK-5
EF on admission 15%. Day of discahrge EF 50-55% per ECHO. Do we answer Y for LVSD<40 . ACHF
Discharged on Anticoagulation Therapy STK
Positive over negative findings STK-OP
Is this considered a stroke clinical trial patient? STK
Discharge Code and Transfers of Patients STK-OP
For patients transfused in Operating Room, how do we respond if there is no "written" order for transfusion. BM-05
Patient Ambulatory At End of Hospital Day 2 STK
The latest update indicates a favorable mRS as 0 1 or 2 post stroke with pre mRS 3 4 or 5 CSTK
NIHSS time STK
Can an addendum be made to a pt's chart that has been d/c - Physician did not place the hunt & hess. CSTK
What value should be selected when VTE prophylaxis is administered several days after admission? STK
Reason for extending IV tPA STK-4
Nimodipine within 24 hours for non-aneurysmal SAH CSTK, CSTK-06
How should Last Known Well be abastracted when there is conflicting documentation in the medical record? STK-04

Clinical Algorithm Questions

Data Quality Questions

Measure Verification Questions

Measure Verification Questions

Technical Questions

Performance Measurement System Vendor - General Questions

Statistical Questions

%DBQUERY{"TopicType =~ 'UserQuestion' AND Status =~ 'Database'"
 web="%BASEWEB%"
 sort="AnsweredDate"
 format="$expand(QuestionCategory)~$web.$topic~$encode($expand(Question))~$expand(RelatedMIFs)~$formatTime(info.date, '$day $mon $year')"
 separator="##"
}%


---++ Clinical Specification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div>
</noautolink>

---++ Clinical Algorithm Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Data Quality Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID01\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID04\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Technical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID02\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Performance Measurement System Vendor - General Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID00\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Statistical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID05\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>


Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine